Cargando…

PReS-FINAL-2054: Latent tuberculosis infection in patients with juvenile idiopathic arthritis undergoing methotrexate therapy: a longitudinal study with TST and ELISPOT

Detalles Bibliográficos
Autores principales:	Sztajnbok, F, Boechat, NL, Oliveira, SK, Ribeiro, SB, Rodrigues, MC, Diniz, C, Sztajnbok, FCDN, Sant'Anna, CC
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044362/ http://dx.doi.org/10.1186/1546-0096-11-S2-P67

Ejemplares similares

Tuberculin skin test and ELISPOT/T. SPOT.TB in children and adolescents with juvenile idiopathic arthritis
por: Sztajnbok, Flavio, et al.
Publicado: (2014)

PReS-FINAL-2296: Thrombocytopenia as a unique manifestation of antiphospholipid syndrome: a case report in the pediatric age
por: Campos, LR, et al.
Publicado: (2013)

PReS-FINAL-2165: Pharmacogenetic determinants of response to methotrexate in juvenile idiopathic arthritis
por: Pastore, S, et al.
Publicado: (2013)

PReS-FINAL-2048: Treatment with methotrexate plus leflunomide for juvenile idiopathic arthritis
por: Quesada-Masachs, E, et al.
Publicado: (2013)

PReS-FINAL-2155: Genetic variability of methotrexate transporters in patients with juvenile idiopathic arthritis
por: Zajc Avramovič, M, et al.
Publicado: (2013)

PReS-FINAL-2100: Methotrexate treatment affects effector, but not regulatory T cells in juvenile idiopathic arthritis
por: Vastert, S, et al.
Publicado: (2013)

PReS-FINAL-2007: Adolescent clinic for young patients with juvenile idiopathic arthritis
por: Sørensen, SK
Publicado: (2013)

PReS-FINAL-2162: Development of a risk model to predict methotrexate intolerance in juvenile idiopathic arthritis
por: Van Dijkhuizen, P, et al.
Publicado: (2013)

Anaphylactic reaction to the first dose of subcutaneous methotrexate in JIA: a case report and literature review
por: Campos, Leonardo, et al.
Publicado: (2014)

La physique des particules en 2054
por: Maiani, Luciano
Publicado: (2004)

PROJECT ADMINISTRATION AGREEMENT KN2054/BE-ESS
por: The European Organization for Nuclear Research, CERN, et al.
Publicado: (2012)

2054. Hospital-initiated Antibiotics in Nursing Homes
por: Furuno, Jon P, et al.
Publicado: (2019)

TST conversions and systemic interferon-gamma increase after methotrexate introduction in psoriasis patients
por: de Medeiros, Vanessa Lucília Silveira, et al.
Publicado: (2020)

PReS-FINAL-2131: Hunting for biomarkers in juvenile dermatomyositis
por: Bellutti Enders, F, et al.
Publicado: (2013)

Diagnosis of Latent Tuberculosis Infection in Hemodialysis Patients: TST versus T-SPOT.TB
por: Binay, Umut Devrim, et al.
Publicado: (2023)

PReS-FINAL-2043: Cardiac involvement in juvenile idiopathic arthritis
por: Rossetto, E, et al.
Publicado: (2013)

PReS-FINAL-2050: Determination of the concentration of methotrexate in the blood serum of patients with JIA
por: Rokhlina, F, et al.
Publicado: (2013)

Argonne: TST tests
Publicado: (1973)

CERN: TST in and working
Publicado: (1978)

PReS-FINAL-2095: Older age predicts poor response to 6-months methotrexate therapy in a juvenile idiopathic arthritis cohort of patients
por: Marques, R, et al.
Publicado: (2013)

PReS-FINAL-2094: Evaluation of the benefits of sequential addition of leflunomide in patients with polyarticular course juvenile idiopathic arthritis failing standard dose methotrexate
por: Chickermane, PR, et al.
Publicado: (2013)

PReS-FINAL-2027: Cerebral demyelination and optic neuritis during treatment with eternacept and methotrexate
por: Christensen, AE, et al.
Publicado: (2013)

PReS-FINAL-2097: Evaluation of gait in children with juvenile idiopathic arthritis
por: Baydogan, SN, et al.
Publicado: (2013)

PReS-FINAL-2008: Juvenile dermatomyositis: a report of 22 cases
por: Souto, A, et al.
Publicado: (2013)

PReS-FINAL-2147: Immunological consequences of biologicals in juvenile idiopathic arthritis
por: Swart, JF, et al.
Publicado: (2013)

PReS-FINAL-2024: Responsiveness of the juvenile arthritis foot disability index
por: Esbjörnsson, AC, et al.
Publicado: (2013)

Comparison of TST and IGRA in Diagnosis of Latent Tuberculosis Infection in a High TB-Burden Setting
por: Sharma, Surendra K., et al.
Publicado: (2017)

PReS-FINAL-2184: A randomized trial in new onset juvenile dermatomyositis: prednisone versus prednisone plus cyclosporine versus prednisone plus methotrexate
por: Ruperto, N, et al.
Publicado: (2013)

Argonne : Essais de TST
Publicado: (1973)

TST (H=6) cycle
por: Evans, J
Publicado: (1989)

TST (H = 6) cycle
por: Evans, J
Publicado: (1989)

PB2054: HIP AND KNEE OSTEOARTHRITIS IN PHILADELPHIA CHROMOSOME-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
por: Holik, H., et al.
Publicado: (2022)

PB2054: EXPOSURE-RESPONSE ANALYSES OF PEGCETACOPLAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
por: Ping, Haili, et al.
Publicado: (2023)

PReS-FINAL-2010: Predictive value of whole-body MRI in juvenile dermatomyositis
por: Malattia, C, et al.
Publicado: (2013)

PReS-FINAL-2081: Accelerometer-assessed daily activity in juvenile idiopathic arthritis
por: Noergaard, M, et al.
Publicado: (2013)

PReS-FINAL-2109: Genetic variations in patients with juvenile idiopathic arthritis and uveitis
por: Reinards, TH, et al.
Publicado: (2013)

PReS-FINAL-2001: The impact of adalimumab on growth in patients with juvenile idiopathic arthritis
por: Ruperto, N, et al.
Publicado: (2013)

PReS-FINAL-2018: The P53 gene polymorphisms and juvenile idiopathic arthritis
por: Kozhevnikov, A, et al.
Publicado: (2013)

PReS-FINAL-2013: Sodium thiosulfate for the treatment of Juvenile Dermatomyositis complicated by calcinosis
por: Pagnini, I, et al.
Publicado: (2013)

PReS-FINAL-2286: Mastitis in an adolescent patient with juvenile systemic lupus erythematous
por: Bica, BE, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_f4fcjtlo8ach5k60hjjnnlmt7a